Hi, what are you looking for?
Investing.com — Despite the decline last week, the S&P 500 experienced a notable post-election rally, largely driven by gains in technology-related companies. However, analysts...
Investing.com – India stocks were lower after the close on Tuesday, as losses in the Fast Moving Consumer Goods, Metals and Healthcare sectors led...
Investing.com — Shares of Novo Nordisk (CSE:NOVOb) continued their upward momentum on Tuesday, rising over 5%, following gains on Monday. This rebound came after...
By Jennifer Rigby LONDON (Reuters) – A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or...
Investing.com – Greece stocks were lower after the close on Tuesday, as losses in the Telecoms, Household and Basic Resources sectors led shares lower....
Investing.com — Shares of Claros Mortgage Trust fell to a record low on Tuesday, dropping by as much as 11% after the company announced...
Investing.com — Morgan Stanley upgraded Shoals Technologies Group Inc (NASDAQ:SHLS) to Overweight from Equal Weight, while brokerage kept its price target at $7 per...
On Tuesday, shares of Chugai Pharmaceutical (TADAWUL:2070) Co. Ltd. closed 3.4% higher, outperforming the broader TOPIX index’s performance by approximately 4%. The rise in...
Investing.com — Bitcoin on Tuesday surged to $108,000 for the first time in its history, marking a significant milestone as it reached a new...
Investing.com — JetBlue Airways (NASDAQ:JBLU) Corp. CEO Joanna Geraghty has urged President-elect Donald Trump to strengthen the country’s air traffic control system. She addressed...
Investing.com — Shares of Air Canada (TSX:AC) dropped 8% following the company’s issuance of 2025 guidance and presentation on its long-term targets. Despite reiterating...
Investing.com — Shares of American health-care companies owning pharmacy benefit management units saw a decrease in value again on Tuesday, extending Monday’s fall. This...
Investing.com — Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) surged 17% following the announcement of successful Phase 2b study results for its investigational drug...